Matthias Friebe
RaNA Therapeutics (United States)(US)
Publications by Year
Research Areas
Radiopharmaceutical Chemistry and Applications, Medical Imaging Techniques and Applications, Cancer, Hypoxia, and Metabolism, Peptidase Inhibition and Analysis, Cell Adhesion Molecules Research
Most-Cited Works
- → Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism(2008)666 cited
- → Synthesis, 18F-Labeling, and in Vitro and in Vivo Studies of Bombesin Peptides Modified with Silicon-Based Building Blocks(2008)123 cited
- → Specific PET Imaging of xC− Transporter Activity Using a 18F-Labeled Glutamate Derivative Reveals a Dominant Pathway in Tumor Metabolism(2011)119 cited
- → Radioimmunotherapy of Solid Tumors by Targeting Extra Domain B Fibronectin: Identification of the Best-Suited Radioimmunoconjugate(2005)105 cited
- → PET Chemistry: The Driving Force in Molecular Imaging(2007)104 cited
- Imaging of tumor angiogenesis using 99mTc-labeled human recombinant anti-ED-B fibronectin antibody fragments.(2006)
- → Dosimetry and First Clinical Evaluation of the New 18F-Radiolabeled Bombesin Analogue BAY 864367 in Patients with Prostate Cancer(2015)70 cited
- → Small-Animal PET of Tumor Angiogenesis Using a 76Br-Labeled Human Recombinant Antibody Fragment to the ED-B Domain of Fibronectin(2007)62 cited
- → Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies(2016)61 cited
- → Novel Chemically Modified Analogues of Neuropeptide Y for Tumor Targeting(2008)59 cited